Involvement of c-Src Tyrosine Kinase in SHP-1 Phosphatase Activation by Ang II AT2 Receptors in Rat Fetal Tissues

被引:24
作者
Alvarez, Sergio E. [1 ]
Seguin, Leonardo R. [1 ]
Villarreal, Rodrigo S. [1 ]
Nahmias, Clara [2 ]
Ciuffo, Gladys M. [1 ]
机构
[1] Univ Nacl San Luis, Inst Multidisciplinario Invest Biol IMIBIO CONICE, Fac Quim, RA-5700 San Luis, Argentina
[2] Univ Paris 05, Inst Cochin, INSERM, Dept Cell Biol,CNRS,UMR8104, F-75014 Paris, France
关键词
ANG II; AT(2) RECEPTORS; SHP-1; ACTIVATION; DEVELOPMENT;
D O I
10.1002/jcb.21866
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
Angiotensin II (Ang II) AT(2) receptors are abundantly expressed in rat fetal tissues where they probably contribute to development. In the present study we examine the effects of Ang II type 2 receptor stimulation on SHP-1 activation. Ang II (10(-7) M) elicits a rapid and transient tyrosine phosphorylation of SRP-1, maximal at 1 min, in a dose-dependent form, blocked by the AT(2) antagonist, PD123319. SHP-1 phosphorylation is followed in time by tyrosine dephosphorylation of different proteins, suggesting a sequence of events. Ang 11 induces association of SHP-1 to AT(2) receptors as shown by co-immunoprecipitation, Western blot and binding assays. SHP-1 activity was determined in immunocomplexes obtained with either anti-AT(2) or anti-SHP-1 antibodies, after Ang II stimulation (1 min), in correlation with the maximal level of SHP-1 phosphorylation. Interestingly, following receptor stimulation (1 min) c-Src was associated to AT(2) or SHP-1 immunocomplexes. Preincubation with the c-Src inhibitor PP2 inhibited SHP-1 activation and c-Src association, thus confirming the participation of c-Src in this pathway. We demonstrated here for the first time the involvement of c-Src in SHP-1 activation via AT2 receptors present in an ex vivo model expressing both receptor subtypes. In this model, AT2 receptors are not constitutively associated to SHP-1 and SHP-1 is not constitutively activated. Thus, we clearly establish that SHP-1 activation, mediated by the AT2 subtype, involves c-Src and precedes protein tyrosine dephosphorylation, in rat fetal membranes. J. Cell. Biocheni. 105: 703-7 11, 2008. (c) 2008 Wiley-Liss, Inc.
引用
收藏
页码:703 / 711
页数:9
相关论文
共 42 条
[1]
Angiotensin II stimulates tyrosine phosphorylation and activation of insulin receptor substrate 1 and protein-tyrosine phosphatase 1D in vascular smooth muscle cells [J].
Ali, MS ;
Schieffer, B ;
Delafontaine, P ;
Bernstein, KE ;
Ling, BN ;
Marrero, MB .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (19) :12373-12379
[2]
Angiotensin II mediates Tyr-dephosphorylation in rat fetal kidney membranes [J].
Alvarez, SE ;
Fuentes, LB ;
Ciuffo, GM .
MOLECULAR AND CELLULAR BIOCHEMISTRY, 2003, 254 (1-2) :137-143
[3]
Autoradiographic localization of angiotensin II receptors in developing rat cerebellum and brainstem [J].
Arce, ME ;
Sanchez, S ;
Seltzer, A ;
Ciuffo, GM .
REGULATORY PEPTIDES, 2001, 99 (01) :53-60
[4]
Angiotensin II type 2 receptors mediate inhibition of mitogen-activated protein kinase cascade and functional activation of SHP-1 tyrosine phosphatase [J].
Bedecs, K ;
Elbaz, N ;
Sutren, M ;
Masson, M ;
Susini, C ;
Strosberg, AD ;
Nahmias, C .
BIOCHEMICAL JOURNAL, 1997, 325 :449-454
[5]
sst2 somatostatin receptor mediates negative regulation of insulin receptor signaling through the tyrosine phosphatase SHP-1 [J].
Bousquet, C ;
Delesque, N ;
Lopez, F ;
Saint-Laurent, N ;
Estève, JP ;
Bedecs, K ;
Buscail, L ;
Vaysse, N ;
Susini, C .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (12) :7099-7106
[6]
Src kinase inhibition promotes the chondrocyte phenotype [J].
Bursell, Laura ;
Woods, Anita ;
James, Claudine G. ;
Pala, Daphne ;
Leask, Andrew ;
Beier, Frank .
ARTHRITIS RESEARCH & THERAPY, 2007, 9 (05)
[7]
Angiotensin II receptors induce tyrosine dephosphorylation in rat fetal membranes [J].
Ciuffo, GM ;
Alvarez, SE ;
Fuentes, LB .
REGULATORY PEPTIDES, 1998, 74 (2-3) :129-135
[8]
Pivotal role of tyrosine phosphatase SHP-1 in AT2 receptor-mediated apoptosis in rat fetal vascular smooth muscle cell [J].
Cui, TX ;
Nakagami, H ;
Iwai, M ;
Takeda, Y ;
Shiuchi, T ;
Daviet, L ;
Nahmias, C ;
Horiuchi, M .
CARDIOVASCULAR RESEARCH, 2001, 49 (04) :863-871
[9]
de Gasparo M, 2000, PHARMACOL REV, V52, P415
[10]
Angiotensin receptors: a new role in cancer? [J].
Deshayes, F ;
Nahmias, C .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2005, 16 (07) :293-299